While low activation levels of this pathway seem to sustain a T-cytotoxic antitumoral effect via a type I interferons-mediated response [27, 28], chronic persistence of DNA damage and release of double-stranded DNA particles with subsequent c-GAS-STING activation may be responsible for a down-regulation of a cancer-related immune response. The gene discussed is STING1; the disease is cancer.